Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia

NCT02862210 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Frontotemporal Dementia (FTD)

Interventions

DRUG: Lithium Carbonate
DRUG: Placebo

Sponsor

Columbia University

Collaborators

[object Object]